Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare Biotechnology

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc

Bullboard Posts

Comment by Snowballgrowthon Aug 18, 2020 3:47pm

79 Views

Post# 31424630

RE:RE:RE:RE:RE:RE:RE:Pre-Boarding Announcement ...

porksniffer wrote:

mjn797979 wrote: They could have bought back already as the share price is even below their buyback average of 7.14$ of last year.

They have yet to do so and to be honest at this point, its not a bullish signal if they buyback some more considering past.

Acquisition is complete now, and we wait again.

6.70$...

Buybacks do not move the price up...they 'attempt' to slow it down from moving lower. Buybacks are not allowed to take out the ASK they are only allowed to sit on the BID and wait for someone to sell to them.

$6.68